NCT06785870View on ClinicalTrials.gov

EVAluation of Erythrocytosis PRospEctive Cohort STudy

Not yet recruitingOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2030

Conditions

ErythrocytosisPolycythemiaPolycythemia SecondaryPolycythemia VeraPolycythemia Vera, Post-Polycythemic Myelofibrosis PhasePolycythemia Vera (PV)Polycythemia; FamilialPolycythemia, Primary

Trial Locations (1)

N6A 5W9

Victoria Hospital, London Health Sciences Centre, London

All Listed Sponsors

lead

Cyrus Hsia

OTHER

NCT06785870 - EVAluation of Erythrocytosis PRospEctive Cohort STudy | Biotech Hunter | Biotech Hunter